GLP-1 Dual Agonist
Head-to-head incretin comparison
Pairs the two leading GLP-1 pathway agonists for comparative metabolic research. Semaglutide provides pure GLP-1 receptor activation while Tirzepatide adds dual GIP/GLP-1 engagement, enabling direct mechanistic comparison studies.
All components ship together with individual COA documentation
How These Work Together
Semaglutide provides pure GLP-1 receptor agonism with a 7-day half-life, enabling sustained incretin pathway activation. Tirzepatide adds GIP receptor co-agonism, engaging a second metabolic pathway that enhances insulin sensitivity and lipid metabolism beyond what GLP-1 alone achieves. Running both compounds enables direct comparison of single vs. dual incretin engagement in the same research model.
Related Stacks
Healing Protocol
The gold standard tissue repair stack
2 components · Tissue Repair
Triple Threat Weight
Three metabolic pathways, one protocol
3 components · Multi-Pathway Weight
Cognitive Enhancement
Neuroprotection meets neuroplasticity
3 components · Neuroprotection & BDNF
Ready to Start This Protocol?
Order the complete GLP-1 Dual Agonist stack at $80.01 and save $8.89 versus buying each component individually.